tert-Butyl (1-imino-1-oxidotetrahydro-1H-1l6-thiophen-3-yl)(methyl)carbamate

Catalog No. :
ACWZEZ667
CAS No. :
2138219-55-1
Molecular Formula :
C10H20N2O3S
Molecular Weight :
248.35

IUPAC Name:tert-butyl (1-imino-1-oxidotetrahydro-1H-1l6-thiophen-3-yl)(methyl)carbamate

tert-Butyl (1-imino-1-oxidotetrahydro-1H-1l6-thiophen-3-yl)(methyl)carbamate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg98%$429.00Login to see priceInquiryInquiry
100mg98%$636.00Login to see priceInquiryInquiry
250mg98%$898.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl (1-imino-1-oxidotetrahydro-1H-1l6-thiophen-3-yl)(methyl)carbamate
IUPAC Nametert-butyl (1-imino-1-oxidotetrahydro-1H-1l6-thiophen-3-yl)(methyl)carbamate
Molecular FormulaC10H20N2O3S
Molecular Weight248.35
SMILESO=C(N(C)C(C1)CCS1(=O)=N)OC(C)(C)C
InChI KeyBCQMKZBTTPTZGQ-UHFFFAOYSA-N
Synonymtert-butyl N-(1-imino-1-oxo-1lambda6-thiolan-3-yl)-N-methylcarbamate;tert-Butyl (1-imino-1-oxidotetrahydro-1H-1l6-thiophen-3-yl)(methyl)carbamate
CAS No.2138219-55-1

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H315-H319
Precautionary Statement(s)
P264-P280-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364

Synthetic Route by SureRoute

1. ACWZEZ667 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACWZEZ667 route product structure diagram
    ACWZEZ6672138219-55-1
Inquiry

2. ACWZEZ667 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACWZEZ667 route product structure diagram
    ACWZEZ6672138219-55-1
Inquiry

Comments (0)